These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 15982805)
1. A thioredoxin reductase inhibitor induces growth inhibition and apoptosis in five cultured human carcinoma cell lines. Zhao F; Yan J; Deng S; Lan L; He F; Kuang B; Zeng H Cancer Lett; 2006 May; 236(1):46-53. PubMed ID: 15982805 [TBL] [Abstract][Full Text] [Related]
2. A novel thioredoxin reductase inhibitor inhibits cell growth and induces apoptosis in HL-60 and K562 cells. Peng ZF; Lan LX; Zhao F; Li J; Tan Q; Yin HW; Zeng HH J Zhejiang Univ Sci B; 2008 Jan; 9(1):16-21. PubMed ID: 18196608 [TBL] [Abstract][Full Text] [Related]
3. The mechanism of apoptosis induced by a novel thioredoxin reductase inhibitor in A549 cells: possible involvement of nuclear factor-kappaB-dependent pathway. Lan L; Zhao F; Wang Y; Zeng H Eur J Pharmacol; 2007 Jan; 555(2-3):83-92. PubMed ID: 17116300 [TBL] [Abstract][Full Text] [Related]
4. The inhibitory effect of a novel organoselenium compound BBSKE on the tongue cancer Tca8113 in vitro and in vivo. Xing F; Li S; Ge X; Wang C; Zeng H; Li D; Dong L Oral Oncol; 2008 Oct; 44(10):963-9. PubMed ID: 18282784 [TBL] [Abstract][Full Text] [Related]
5. A novel organoselenium compound induces cell cycle arrest and apoptosis in prostate cancer cell lines. Shi C; Yu L; Yang F; Yan J; Zeng H Biochem Biophys Res Commun; 2003 Sep; 309(3):578-83. PubMed ID: 12963029 [TBL] [Abstract][Full Text] [Related]
6. [Induction of apoptosis in prostate cancer cell line PC-3 by BBSKE, a novel organoselenium compound, and its effect in vivo]. Shi CJ; Zeng HH; Li HW; Yang FG; Wu XQ; Yu LZ Zhonghua Yi Xue Za Zhi; 2003 Nov; 83(22):1984-8. PubMed ID: 14703435 [TBL] [Abstract][Full Text] [Related]
7. Synergism between thioredoxin reductase inhibitor ethaselen and sodium selenite in inhibiting proliferation and inducing death of human non-small cell lung cancer cells. Zheng X; Xu W; Sun R; Yin H; Dong C; Zeng H Chem Biol Interact; 2017 Sep; 275():74-85. PubMed ID: 28757135 [TBL] [Abstract][Full Text] [Related]
8. [Correlation of plasma thioredoxin reductase activity to growth of H22 hepatocellular carcinoma xenografts in Kunming mice]. Tan Q; Ren XY; Li J; Wang F; Deng SJ; Zeng HH Ai Zheng; 2009 May; 28(5):472-7. PubMed ID: 19624873 [TBL] [Abstract][Full Text] [Related]
9. Dose-biomarker-response modeling of the anticancer effect of ethaselen in a human non-small cell lung cancer xenograft mouse model. Ye SF; Li J; Ji SM; Zeng HH; Lu W Acta Pharmacol Sin; 2017 Feb; 38(2):223-232. PubMed ID: 27917873 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy. He J; Li D; Xiong K; Ge Y; Jin H; Zhang G; Hong M; Tian Y; Yin J; Zeng H Bioorg Med Chem; 2012 Jun; 20(12):3816-27. PubMed ID: 22579620 [TBL] [Abstract][Full Text] [Related]
11. Selenium-containing thioredoxin reductase inhibitor ethaselen sensitizes non-small cell lung cancer to radiotherapy. Wang L; Fu JN; Wang JY; Jin CJ; Ren XY; Tan Q; Li J; Yin HW; Xiong K; Wang TY; Liu XM; Zeng HH Anticancer Drugs; 2011 Sep; 22(8):732-40. PubMed ID: 21562407 [TBL] [Abstract][Full Text] [Related]
12. Novel mechanism of ethaselen in poorly differentiated colorectal RKO cell growth inhibition: Simultaneous regulation of TrxR transcription, expression and enzyme activity. Yin H; Li J; Xiong K; Wang L; Wang T; Tan Q; Fu J; Ren X; Zeng H Differentiation; 2011 Jan; 81(1):49-56. PubMed ID: 20864247 [TBL] [Abstract][Full Text] [Related]
13. Synergistic inhibition of sunitinib and ethaselen against human colorectal cancer cells proliferation. Zheng X; Zhang Y; Zhang L; Xu W; Ma W; Sun R; Zeng H Biomed Pharmacother; 2016 Oct; 83():212-220. PubMed ID: 27372405 [TBL] [Abstract][Full Text] [Related]
14. The antimetastatic effect and underlying mechanisms of thioredoxin reductase inhibitor ethaselen. Zheng X; Chen Y; Bai M; Liu Y; Xu B; Sun R; Zeng H Free Radic Biol Med; 2019 Feb; 131():7-17. PubMed ID: 30496814 [TBL] [Abstract][Full Text] [Related]
15. Norcantharidin induces apoptosis in HeLa cells through caspase, MAPK, and mitochondrial pathways. An WW; Gong XF; Wang MW; Tashiro S; Onodera S; Ikejima T Acta Pharmacol Sin; 2004 Nov; 25(11):1502-8. PubMed ID: 15525474 [TBL] [Abstract][Full Text] [Related]
16. Preparation of tri-block copolymer micelles loading novel organoselenium anticancer drug BBSKE and study of tissue distribution of copolymer micelles by imaging in vivo method. Liu M; Fu J; Li J; Wang L; Tan Q; Ren X; Peng Z; Zeng H Int J Pharm; 2010 May; 391(1-2):292-304. PubMed ID: 20211232 [TBL] [Abstract][Full Text] [Related]
17. Thioredoxin reductase inhibitor ethaselen increases the drug sensitivity of the colon cancer cell line LoVo towards cisplatin via regulation of G1 phase and reversal of G2/M phase arrest. Fu JN; Li J; Tan Q; Yin HW; Xiong K; Wang TY; Ren XY; Zeng HH Invest New Drugs; 2011 Aug; 29(4):627-36. PubMed ID: 20195699 [TBL] [Abstract][Full Text] [Related]
18. Augmented antitumor effects of combination therapy of cisplatin with ethaselen as a novel thioredoxin reductase inhibitor on human A549 cell in vivo. Tan Q; Li J; Yin HW; Wang LH; Tang WC; Zhao F; Liu XM; Zeng HH Invest New Drugs; 2010 Jun; 28(3):205-15. PubMed ID: 19271154 [TBL] [Abstract][Full Text] [Related]